艾洛替尼耐药肝癌HepG2细胞系的建立及其耐药机制
任志广;赵青;魏寅祥;贾砚寒;李新颖;黎燕;彭晖;马远方
艾洛替尼耐药肝癌HepG2细胞系的建立及其耐药机制
Establishment of erlotinib-resistant HepG2 cell line and its resistant mechanisms
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |